Filing Details

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 13D/A
(Rule 13d-101)

Information to be Included in Statements Filed Pursuant
to § 240.13d-1(a) and Amendments Thereto Filed
Pursuant to § 240.13d-2(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

---

___________________________________________

Notes:

___________________________________________

Notes:

This Amendment No. 4 amends and supplements the disclosures in Items 3 and 4 of the Schedule 13D (the “Schedule 13D”) filed with the Securities and Exchange Commission on January 3, 2024, as amended by amendments thereto filed on January 30, 2024, January 22, 2024 and January 9, 2024, relating to the Common Units. Except as specifically provided herein, the disclosures set forth in the Schedule 13D remain unchanged.

Item 3. Source and Amount of Funds or Other Consideration

Item 3 of the Schedule 13D is hereby amended and supplemented as follows:

From January 30, 2024 to February 23, 2024, the Company, individually and through its wholly-owned subsidiaries, Ascetico Limited and Paparebecrop Limited, acquired 30,000, 524,001 and 9,200 Common Units, respectively, in open-market transactions for an aggregate purchase prices of $555,636, $9,525,858 and $205,207, respectively. The source of funds used for these transactions was working capital of the Company.

Item 4. Purpose of Transaction

Item 4 of the Schedule 13D is hereby deleted and replaced in its entirety as follows:

The information set forth in Item 3 is hereby incorporated by reference in its entirety.

The Reporting Persons acquired the Common Units of the Issuer for investment purposes as they believed that such Common Units represented an attractive investment opportunity.

The Reporting Persons intend to review their investment in the Issuer from time to time on the basis of various factors, including the Issuer’s business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer’s stock in particular, as well as other developments.

The Reporting Persons reserve the right, based on all relevant factors and subject to applicable law or other restrictions, at any time and from time to time, directly or through wholly owned subsidiaries, to acquire additional Common Units, dispose of some or all of the Common Units that it may own from time to time, in each case in open market or private transactions, block sales or otherwise, and review or reconsider their position, change their purpose, take other actions or formulate and implement plans or proposals with respect to any of the foregoing.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 26, 2024

Annex A

The following table lists the directors and executive officers of Yoda PLC.